Pharma & Biotech News #PharmaBuzz

Weekly News Recap #Phispers

FDA approves J&J's plaque psoriasis pill; federal judge blocks key parts of RFK Jr's childhood vaccine policy overhaul

As the war in the Middle East intensifies, the world is facing disruption of major air and sea routes. The war is already disr...

Impressions : 738

Lilly to invest US$ 3 bn in China to boost supply of new obesity drug; Servier acquires Day One Biopharma for US$ 2.5 bn

In Phispers this week, Eli Lilly announced its plans to invest US$ 3 billion in China over the next decade in order to build p...

Impressions : 2117

Moderna resolves vaccine patent dispute with Roivant, Arbutus; FDA grants accelerated approval to Ascendis' dwarfism therapy

Over the past week, tensions in the Middle East have escalated sharply after the US and Israel launched military strikes on Ira...

Impressions : 592

Gilead buys Arcellx for US$ 7.8 billion; FDA approves Vanda's antipsychotic pill for bipolar disorder, schizophrenia

In this week’s news, Gilead Sciences has entered into an agreement to acquire its cancer therapy partner Arcellx for US$ ...

Impressions : 681